Sinopharm Group Co. Ltd.
$11.27+0.45%(+$0.05)
TickerSpark Score
52/100
87
Valuation
55
Profitability
20
Growth
68
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHTDY research report →
52-Week Range5% of range
Low $11.09
Current $11.27
High $14.87
Companywww.sinopharmgroup.com.cn
Sinopharm Group Co. Ltd. , together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China.
- CEO
- Wanyong Lian
- IPO
- 2016
- Employees
- 108,217
- HQ
- Shanghai, CN
Price Chart
-2.68% · this period
Valuation
- Market Cap
- $7.03B
- P/E
- 6.66
- P/S
- 0.08
- P/B
- 0.57
- EV/EBITDA
- 4.64
- Div Yield
- 4.22%
Profitability
- Gross Margin
- 7.32%
- Op Margin
- 2.74%
- Net Margin
- 1.24%
- ROE
- 8.70%
- ROIC
- 4.68%
Growth & Income
- Revenue
- $559.50B · -4.28%
- Net Income
- $6.96B · -1.27%
- EPS
- $11.10 · -1.77%
- Op Income
- $16.21B
- FCF YoY
- 30.73%
Performance & Tape
- 52W High
- $14.87
- 52W Low
- $11.09
- 50D MA
- $12.59
- 200D MA
- $12.69
- Beta
- 0.48
- Avg Volume
- 70.28K
Get TickerSpark's AI analysis on SHTDY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SHTDY Coverage
We haven't published any research on SHTDY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SHTDY Report →